1284 related articles for article (PubMed ID: 22064426)
1. Tumor angiogenesis: molecular pathways and therapeutic targets.
Weis SM; Cheresh DA
Nat Med; 2011 Nov; 17(11):1359-70. PubMed ID: 22064426
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of tumor neovascularization.
Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
[TBL] [Abstract][Full Text] [Related]
4. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
5. [VEGF in neoplastic angiogenesis].
Chekhonin VP; Shein SA; Korchagina AA; Gurina OI
Vestn Ross Akad Med Nauk; 2012; (2):23-33. PubMed ID: 22642175
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis in cancer therapy.
Ichihara E; Kiura K; Tanimoto M
Acta Med Okayama; 2011 Dec; 65(6):353-62. PubMed ID: 22189475
[TBL] [Abstract][Full Text] [Related]
7. Pathological angiogenesis and inflammation in tissues.
Jeong JH; Ojha U; Lee YM
Arch Pharm Res; 2021 Jan; 44(1):1-15. PubMed ID: 33230600
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in melanoma.
Mahabeleshwar GH; Byzova TV
Semin Oncol; 2007 Dec; 34(6):555-65. PubMed ID: 18083379
[TBL] [Abstract][Full Text] [Related]
9. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
10. Overview of angiogenesis: Biologic implications for antiangiogenic therapy.
Ellis LM; Liu W; Ahmad SA; Fan F; Jung YD; Shaheen RM; Reinmuth N
Semin Oncol; 2001 Oct; 28(5 Suppl 16):94-104. PubMed ID: 11706401
[TBL] [Abstract][Full Text] [Related]
11. Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment.
Rani V; Prabhu A
Curr Pharm Des; 2021; 27(7):919-931. PubMed ID: 33006535
[TBL] [Abstract][Full Text] [Related]
12. Signaling pathways governing tumor angiogenesis.
Sakurai T; Kudo M
Oncology; 2011; 81 Suppl 1():24-9. PubMed ID: 22212932
[TBL] [Abstract][Full Text] [Related]
13. Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
[TBL] [Abstract][Full Text] [Related]
14. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
15. Synopsis of angiogenesis inhibitors in oncology.
Ellis LM; Liu W; Fan F; Jung YD; Reinmuth N; Stoeltzing O; Takeda A; Akagi M; Parikh AA; Ahmad S
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):14-22. PubMed ID: 12102576
[TBL] [Abstract][Full Text] [Related]
16. Controlling escape from angiogenesis inhibitors.
Sennino B; McDonald DM
Nat Rev Cancer; 2012 Oct; 12(10):699-709. PubMed ID: 23001349
[TBL] [Abstract][Full Text] [Related]
17. Development of new drugs in angiogenesis.
Ziche M; Donnini S; Morbidelli L
Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
Yetkin-Arik B; Kastelein AW; Klaassen I; Jansen CHJR; Latul YP; Vittori M; Biri A; Kahraman K; Griffioen AW; Amant F; Lok CAR; Schlingemann RO; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188446. PubMed ID: 33058997
[TBL] [Abstract][Full Text] [Related]
19. Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis.
Andreuzzi E; Capuano A; Poletto E; Pivetta E; Fejza A; Favero A; Doliana R; Cannizzaro R; Spessotto P; Mongiat M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456248
[TBL] [Abstract][Full Text] [Related]
20. The angiogenic process as a therapeutic target in cancer.
Bridges EM; Harris AL
Biochem Pharmacol; 2011 May; 81(10):1183-91. PubMed ID: 21382350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]